Kestra Medical Technologies (KMTS) Interest Expenses (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Interest Expenses data on file, last reported at $1.8 million in Q2 2026.

• On a quarterly basis, Interest Expenses fell 55.08% year-over-year to $1.8 million in Q2 2026; TTM through Apr 2026 was $9.6 million, a 4.32% decrease from a year earlier, with the FY2026 full-year figure at $126.0 million, up 21.33% from the prior year.
• Interest Expenses for Q2 2026 stood at $1.8 million, down from $34.7 million in the prior quarter.
• Over the last five years, Interest Expenses for KMTS reached as high as $47.3 million in Q4 2025 and fell as low as $1.7 million in Q1 2024.
• Historically, Interest Expenses has averaged $9.9 million across 3 years, with a median of $1.9 million in 2024.
• Across the five-year window, Interest Expenses surged 1943.25% in 2025 and tumbled 55.08% in 2026, its largest moves.
• Year by year, Interest Expenses stood at $2.3 million in 2024, then jumped by 1943.25% to $47.3 million in 2025, then tumbled by 96.1% to $1.8 million in 2026.
• Per Business Quant data, the three most recent Interest Expenses figures were $1.8 million in Q2 2026, $34.7 million in Q1 2026, and $47.3 million in Q4 2025.